Xarelto (rivaroxaban) and Eliquis (apixaban) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat or help prevent blood clots in certain ...

A new oral suspension formulation of Xarelto has also been approved by the FDA. The Food and Drug Administration (FDA) has approved Xarelto ® (rivaroxaban) for 2 new pediatric indications: treatment ...

Older adults taking Bayer AG's blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious bleeding and stroke compared to those taking ...

Data presentations at AHA 2023 Meeting reinforce treatment with XARELTO ® plus aspirin consistently reduces major cardiovascular events (MACE) as well as major adverse limb events (MALE) in complex ...

Trailing a big-selling rival from Pfizer and Bristol Myers Squibb, Bayer and Johnson & Johnson are looking for any opportunity to bolster their aging heart drug Xarelto. Now, just short of its 10th ...

The NDA submission is supported by data from the phase 3 EINSTEIN-Jr and UNIVERSE trials in pediatric patients, along with adequate and well-controlled studies in adults. A New Drug Application (NDA) ...

An analysis showed benefit of XARELTO ® plus aspirin in reducing thrombotic hospitalizations for PAD patients with and without chronic kidney disease (CKD) A separate analysis demonstrated PAD ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Roach: I have a history of polyps. I recently had nasal polyps removed, and a previous colonoscopy had also revealed ...